377 related articles for article (PubMed ID: 2497184)
21. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency.
Polmar SH
Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649
[TBL] [Abstract][Full Text] [Related]
22. A lymphoblastoid cell line from an adenosine deaminase deficient patient established by Epstein-Barr virus.
Tsuchiya S; Narisawa K; Konno T; Tada K
Tohoku J Exp Med; 1979 Oct; 129(2):105-10. PubMed ID: 227140
[TBL] [Abstract][Full Text] [Related]
23. ADA and PNP deficiencies: how it all began.
Giblett ER
Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
[No Abstract] [Full Text] [Related]
24. Adenosine deaminase deficiency increases thymic apoptosis and causes defective T cell receptor signaling.
Apasov SG; Blackburn MR; Kellems RE; Smith PT; Sitkovsky MV
J Clin Invest; 2001 Jul; 108(1):131-41. PubMed ID: 11435465
[TBL] [Abstract][Full Text] [Related]
25. Normal and mutant human adenosine deaminase genes.
Akeson AL; Wiginton DA; Hutton JJ
J Cell Biochem; 1989 Mar; 39(3):217-28. PubMed ID: 2651461
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase.
Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV
Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047
[TBL] [Abstract][Full Text] [Related]
27. Adenosine deaminase deficiency in combined immunologic deficiency disease.
Meuwissen HJ; Pickering RJ; Pollara B
Birth Defects Orig Artic Ser; 1975; 11(1):117-9. PubMed ID: 1148375
[TBL] [Abstract][Full Text] [Related]
28. The effects of an induced adenosine deaminase deficiency on T-cell differentiation in the rat.
Barton RW
Cell Immunol; 1985 Oct; 95(2):297-310. PubMed ID: 3876160
[TBL] [Abstract][Full Text] [Related]
29. [Immune insufficiency in enzyme defects of purine metabolism].
Müller G
Z Gesamte Inn Med; 1983 Feb; 38(3):83-9. PubMed ID: 6303005
[TBL] [Abstract][Full Text] [Related]
30. Heterogeneity of biochemical, clinical and immunological parameters in severe combined immunodeficiency due to adenosine deaminase deficiency.
Morgan G; Levinsky RJ; Hugh-Jones K; Fairbanks LD; Morris GS; Simmonds HA
Clin Exp Immunol; 1987 Dec; 70(3):491-9. PubMed ID: 3436096
[TBL] [Abstract][Full Text] [Related]
31. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
[TBL] [Abstract][Full Text] [Related]
32. [Polyethylene glycol-adenosine deaminase: a new adenosine deaminase deficiency therapy. Value of deoxyadenosine triphosphate determination for therapeutic monitoring].
Bory C; Boulieu R; Souillet G; Hershfield MS
Therapie; 1991; 46(4):323-6. PubMed ID: 1948809
[TBL] [Abstract][Full Text] [Related]
33. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
Albert D; Bluestein HG; Thompson L; Seegmiller JE
Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
[TBL] [Abstract][Full Text] [Related]
34. Plasma deoxyadenosine, adenosine, and erythrocyte deoxyATP are elevated at birth in an adenosine deaminase-deficient child.
Hirschhorn R; Roegner V; Rubinstein A; Papageorgiou P
J Clin Invest; 1980 Mar; 65(3):768-71. PubMed ID: 6965496
[TBL] [Abstract][Full Text] [Related]
35. 2'Deoxycoformycin and deoxyadenosine affect IL 2 production and IL 2 receptor expression of human T cells.
Ruers TJ; Buurman WA; van der Linden CJ
J Immunol; 1987 Jan; 138(1):116-22. PubMed ID: 3097141
[TBL] [Abstract][Full Text] [Related]
36. Adenosine deaminase deficiency and immunodeficiencies.
Hirschhorn R
Fed Proc; 1977 Jul; 36(8):2166-70. PubMed ID: 872949
[TBL] [Abstract][Full Text] [Related]
37. Immunoreconstitution by peripheral blood leukocytes in adenosine deaminase-deficient severe combined immunodeficiency.
Rich KC; Richman CM; Mejias E; Daddona P
J Clin Invest; 1980 Aug; 66(2):389-95. PubMed ID: 7400322
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow transplantation only partially restores purine metabolites to normal in adenosine deaminase-deficient patients.
Hirschhorn R; Roegner-Maniscalco V; Kuritsky L; Rosen FS
J Clin Invest; 1981 Dec; 68(6):1387-93. PubMed ID: 7033281
[TBL] [Abstract][Full Text] [Related]
39. T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase.
Weinberg K; Hershfield MS; Bastian J; Kohn D; Sender L; Parkman R; Lenarsky C
J Clin Invest; 1993 Aug; 92(2):596-602. PubMed ID: 8349799
[TBL] [Abstract][Full Text] [Related]
40. Genetic heterogeneity in adenosine deaminase (ADA) deficiency: five different mutations in five new patients with partial ADA deficiency.
Hirschhorn R; Ellenbogen A
Am J Hum Genet; 1986 Jan; 38(1):13-25. PubMed ID: 3946419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
